Qube Research & Technologies (QRT)’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $248M | Buy |
640,181
+527,464
| +468% | +$196M | 0.23% | 95 |
|
|
2026
Q1 | $33M | Buy |
+112,717
| New | +$37M | 0.04% | 610 |
|
|
2025
Q2 | – | Sell |
-42,576
| Closed | -$17.1M | – | 3642 |
|
|
2025
Q1 | $18.5M | Sell |
42,576
-437,207
| -91% | -$176M | 0.02% | 786 |
|
|
2024
Q4 | $177M | Buy |
479,783
+281,322
| +142% | +$118M | 0.23% | 89 |
|
|
2024
Q3 | $103M | Buy |
198,461
+143,632
| +262% | +$76.7M | 0.15% | 148 |
|
|
2024
Q2 | $29.7M | Sell |
54,829
-382,772
| -87% | -$202M | 0.05% | 461 |
|
|
2024
Q1 | $227M | Buy |
437,601
+85,122
| +24% | +$42.3M | 0.36% | 46 |
|
|
2023
Q4 | $166M | Sell |
352,479
-139,025
| -28% | -$64.3M | 0.32% | 62 |
|
|
2023
Q3 | $214M | Buy |
491,504
+182,889
| +59% | +$83M | 0.56% | 25 |
|
|
2023
Q2 | $137M | Buy |
+308,615
| New | +$142M | 0.5% | 31 |
|
|
2023
Q1 | – | Sell |
-67,299
| Closed | -$34.5M | – | 2666 |
|
|
2022
Q4 | $34.5M | Sell |
67,299
-31,954
| -32% | -$16.2M | 0.18% | 138 |
|
|
2022
Q3 | $45.1M | Buy |
99,253
+54,194
| +120% | +$25.9M | 0.27% | 81 |
|
|
2022
Q2 | $21.7M | Buy |
45,059
+43,551
| +2,888% | +$21.5M | 0.16% | 160 |
|
|
2022
Q1 | $741K | Sell |
1,508
-1,738
| -54% | -$794K | 0.01% | 1328 |
|
|
2021
Q4 | $1.5M | Buy |
+3,246
| New | +$1.37M | 0.01% | 964 |
|
|
2021
Q3 | – | Sell |
-25,326
| Closed | -$9.67M | – | 2348 |
|
|
2021
Q2 | $9.67M | Buy |
25,326
+7,594
| +43% | +$2.9M | 0.11% | 215 |
|
|
2021
Q1 | $6.37M | Sell |
17,732
-19,227
| -52% | -$6.18M | 0.1% | 249 |
|
|
2020
Q4 | $11.9M | Buy |
+36,959
| New | +$11.3M | 0.17% | 121 |
|
|
2020
Q3 | – | Sell |
-51,277
| Closed | -$13.5M | – | 1781 |
|
|
2020
Q2 | $13.5M | Buy |
+51,277
| New | +$13.7M | 0.2% | 117 |
|
|
2020
Q1 | – | Sell |
-5,666
| Closed | -$1.71M | – | 1257 |
|
|
2019
Q4 | $1.71M | Buy |
5,666
+4,057
| +252% | +$1.12M | 0.05% | 402 |
|
|
2019
Q3 | $386K | Buy |
+1,609
| New | +$441K | 0.26% | 117 |
|
|
2019
Q2 | – | Sell |
-11,552
| Closed | -$3.31M | – | 447 |
|
|
2019
Q1 | $3.31M | Buy |
11,552
+8,494
| +278% | +$2.46M | 0.44% | 55 |
|
|
2018
Q4 | $803K | Buy |
3,058
+1,100
| +56% | +$302K | 0.35% | 59 |
|
|
2018
Q3 | $537K | Buy |
1,958
+264
| +16% | +$68.5K | 0.07% | 208 |
|
|
2018
Q2 | $403K | Sell |
1,694
-633
| -27% | -$147K | 0.25% | 82 |
|
|
2018
Q1 | $511K | Buy |
+2,327
| New | +$547K | 0.2% | 71 |
|
Other funds holding ELV
Qube Research & Technologies (QRT)'s ELV Position: Q2 2026 in Review
Qube Research & Technologies (QRT) increased its Elevance Health (ELV) stake by 468% in Q2 2026, buying an estimated $196M and bringing the position to 640,181 shares worth $248M. The position accounts for 0.23% of the portfolio, ranked #95.
Qube Research & Technologies (QRT) first reported a position in ELV in Q1 2018 and has held it in 26 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Qube Research & Technologies (QRT) held 640,181 shares of Elevance Health worth $248M as of Q2 2026.
- Qube Research & Technologies (QRT) bought 527,464 Elevance Health shares in Q2 2026, an estimated $196M.
- Elevance Health made up 0.23% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #95 holding.
- Qube Research & Technologies (QRT) first reported a position in Elevance Health in Q1 2018 and has held it in 26 quarters since.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.